Shivalik Rasayan Ltd submits USMDF for API 'PALBOCICLIB'

Shivalik Rasayan Limited have successfully submitted USMDF for API "PALBOCICLIB" to USFDA today. The PALBOCICLIB is used for Breast Cancer and is under Patent in US till 2026.

Shares of Shivalik Rasayan Ltd was last trading in BSE at Rs. 681.25 as compared to the previous close of Rs. 691.95. The total number of shares traded during the day was 1869 in over 195 trades.

The stock hit an intraday high of Rs. 702.00 and intraday low of 677.00. The net turnover during the day was Rs. 1275902.00.

Source : Equity Bulls

Keywords

ShivalikRasayan INE788J01021 USMDF API PALBOCICLIB